HEADER TRANSFERASE/TRANSFERASE INHIBITOR 24-SEP-16 5TF9 TITLE CRYSTAL STRUCTURE OF WNK1 IN COMPLEX WITH MN2+AMPPNP AND WNK476 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE WNK1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 206-483; COMPND 5 SYNONYM: ERYTHROCYTE 65 KDA PROTEIN, P65, KINASE DEFICIENT PROTEIN, COMPND 6 PROTEIN KINASE LYSINE-DEFICIENT 1, PROTEIN KINASE WITH NO LYSINE 1, COMPND 7 HWNK1; COMPND 8 EC: 2.7.11.1; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: WNK1, HSN2, KDP, KIAA0344, PRKWNK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI K-12; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 83333 KEYWDS SERINE-THREONINE-PROTEIN KINASE, INHIBITOR, TERNARY, COMPLEX, KEYWDS 2 ALLOSTERIC, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR X.XIE,J.GUNAWAN REVDAT 3 04-OCT-23 5TF9 1 LINK REVDAT 2 28-DEC-16 5TF9 1 JRNL REVDAT 1 19-OCT-16 5TF9 0 JRNL AUTH K.YAMADA,J.H.ZHANG,X.XIE,J.REINHARDT,A.Q.XIE,D.LASALA, JRNL AUTH 2 D.KOHLS,D.YOWE,D.BURDICK,H.YOSHISUE,H.WAKAI,I.SCHMIDT, JRNL AUTH 3 J.GUNAWAN,K.YASOSHIMA,Q.K.YUE,M.KATO,M.MOGI,N.IDAMAKANTI, JRNL AUTH 4 N.KREDER,P.DRUECKES,P.PANDEY,T.KAWANAMI,W.HUANG,Y.I.YAGI, JRNL AUTH 5 Z.DENG,H.M.PARK JRNL TITL DISCOVERY AND CHARACTERIZATION OF ALLOSTERIC WNK KINASE JRNL TITL 2 INHIBITORS. JRNL REF ACS CHEM. BIOL. V. 11 3338 2016 JRNL REFN ESSN 1554-8937 JRNL PMID 27712055 JRNL DOI 10.1021/ACSCHEMBIO.6B00511 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.03 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 18442 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.730 REMARK 3 FREE R VALUE TEST SET COUNT : 872 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.0323 - 4.5410 1.00 3000 106 0.1750 0.2035 REMARK 3 2 4.5410 - 3.6051 1.00 2937 141 0.1690 0.2411 REMARK 3 3 3.6051 - 3.1496 1.00 2881 172 0.2030 0.2663 REMARK 3 4 3.1496 - 2.8617 1.00 2942 139 0.2308 0.3369 REMARK 3 5 2.8617 - 2.6566 1.00 2904 145 0.2351 0.3359 REMARK 3 6 2.6566 - 2.5000 1.00 2906 169 0.2573 0.3306 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.360 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.080 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.83 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4457 REMARK 3 ANGLE : 1.014 6011 REMARK 3 CHIRALITY : 0.065 656 REMARK 3 PLANARITY : 0.004 743 REMARK 3 DIHEDRAL : 27.369 1677 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5TF9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-SEP-16. REMARK 100 THE DEPOSITION ID IS D_1000224145. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUN-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18658 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.08600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.54 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.46800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3FPQ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM HEPES, PH 7.5, 200 MM CALCIUM REMARK 280 ACETATE, 22% PEG3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 41.53250 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.24100 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 41.53250 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 52.24100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1030 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 205 REMARK 465 GLU A 206 REMARK 465 LEU A 207 REMARK 465 GLU A 208 REMARK 465 THR A 209 REMARK 465 GLY A 293 REMARK 465 LYS A 294 REMARK 465 LYS A 295 REMARK 465 ARG A 376 REMARK 465 ALA A 377 REMARK 465 ASP A 378 REMARK 465 PHE A 379 REMARK 465 ALA A 380 REMARK 465 LYS A 381 REMARK 465 SER A 382 REMARK 465 VAL A 383 REMARK 465 ILE A 384 REMARK 465 GLY B 205 REMARK 465 ARG B 376 REMARK 465 ALA B 377 REMARK 465 ASP B 378 REMARK 465 PHE B 379 REMARK 465 ALA B 380 REMARK 465 LYS B 381 REMARK 465 SER B 382 REMARK 465 VAL B 383 REMARK 465 ILE B 384 REMARK 465 GLU B 481 REMARK 465 GLU B 482 REMARK 465 THR B 483 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 267 OG SER B 260 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 257 CB - CG - CD2 ANGL. DEV. = -21.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 257 72.06 -111.69 REMARK 500 ARG A 348 -6.51 73.71 REMARK 500 ASP A 368 74.88 44.50 REMARK 500 ARG B 348 -7.52 70.25 REMARK 500 PHE B 389 46.75 -103.55 REMARK 500 ALA B 397 2.77 -64.67 REMARK 500 ASP B 400 -150.09 -147.30 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 VAL B 291 LYS B 292 -34.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN A 503 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 354 OD1 REMARK 620 2 ASP A 368 OD2 85.9 REMARK 620 3 ANP A 502 O1A 164.6 104.7 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 504 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER A 423 O REMARK 620 2 CYS A 425 O 67.2 REMARK 620 3 HOH A 637 O 81.8 75.5 REMARK 620 4 HOH B 638 O 83.2 145.4 83.2 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MN B 503 MN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN B 354 OD1 REMARK 620 2 ASP B 368 OD2 83.0 REMARK 620 3 ANP B 502 O2A 146.8 74.8 REMARK 620 4 HOH B 646 O 106.9 94.8 99.5 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7AV A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ANP A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MN A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CA A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7AV B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ANP B 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MN B 503 DBREF 5TF9 A 206 483 UNP Q9H4A3 WNK1_HUMAN 206 483 DBREF 5TF9 B 206 483 UNP Q9H4A3 WNK1_HUMAN 206 483 SEQADV 5TF9 GLY A 205 UNP Q9H4A3 EXPRESSION TAG SEQADV 5TF9 ASP A 378 UNP Q9H4A3 SER 378 CONFLICT SEQADV 5TF9 ALA A 396 UNP Q9H4A3 GLU 396 CONFLICT SEQADV 5TF9 ALA A 397 UNP Q9H4A3 GLU 397 CONFLICT SEQADV 5TF9 ALA A 398 UNP Q9H4A3 LYS 398 CONFLICT SEQADV 5TF9 GLY B 205 UNP Q9H4A3 EXPRESSION TAG SEQADV 5TF9 ASP B 378 UNP Q9H4A3 SER 378 CONFLICT SEQADV 5TF9 ALA B 396 UNP Q9H4A3 GLU 396 CONFLICT SEQADV 5TF9 ALA B 397 UNP Q9H4A3 GLU 397 CONFLICT SEQADV 5TF9 ALA B 398 UNP Q9H4A3 LYS 398 CONFLICT SEQRES 1 A 279 GLY GLU LEU GLU THR LYS ALA VAL GLY MET SER ASN ASP SEQRES 2 A 279 GLY ARG PHE LEU LYS PHE ASP ILE GLU ILE GLY ARG GLY SEQRES 3 A 279 SER PHE LYS THR VAL TYR LYS GLY LEU ASP THR GLU THR SEQRES 4 A 279 THR VAL GLU VAL ALA TRP CYS GLU LEU GLN ASP ARG LYS SEQRES 5 A 279 LEU THR LYS SER GLU ARG GLN ARG PHE LYS GLU GLU ALA SEQRES 6 A 279 GLU MET LEU LYS GLY LEU GLN HIS PRO ASN ILE VAL ARG SEQRES 7 A 279 PHE TYR ASP SER TRP GLU SER THR VAL LYS GLY LYS LYS SEQRES 8 A 279 CYS ILE VAL LEU VAL THR GLU LEU MET THR SER GLY THR SEQRES 9 A 279 LEU LYS THR TYR LEU LYS ARG PHE LYS VAL MET LYS ILE SEQRES 10 A 279 LYS VAL LEU ARG SER TRP CYS ARG GLN ILE LEU LYS GLY SEQRES 11 A 279 LEU GLN PHE LEU HIS THR ARG THR PRO PRO ILE ILE HIS SEQRES 12 A 279 ARG ASP LEU LYS CYS ASP ASN ILE PHE ILE THR GLY PRO SEQRES 13 A 279 THR GLY SER VAL LYS ILE GLY ASP LEU GLY LEU ALA THR SEQRES 14 A 279 LEU LYS ARG ALA ASP PHE ALA LYS SER VAL ILE GLY THR SEQRES 15 A 279 PRO GLU PHE MET ALA PRO GLU MET TYR ALA ALA ALA TYR SEQRES 16 A 279 ASP GLU SER VAL ASP VAL TYR ALA PHE GLY MET CYS MET SEQRES 17 A 279 LEU GLU MET ALA THR SER GLU TYR PRO TYR SER GLU CYS SEQRES 18 A 279 GLN ASN ALA ALA GLN ILE TYR ARG ARG VAL THR SER GLY SEQRES 19 A 279 VAL LYS PRO ALA SER PHE ASP LYS VAL ALA ILE PRO GLU SEQRES 20 A 279 VAL LYS GLU ILE ILE GLU GLY CYS ILE ARG GLN ASN LYS SEQRES 21 A 279 ASP GLU ARG TYR SER ILE LYS ASP LEU LEU ASN HIS ALA SEQRES 22 A 279 PHE PHE GLN GLU GLU THR SEQRES 1 B 279 GLY GLU LEU GLU THR LYS ALA VAL GLY MET SER ASN ASP SEQRES 2 B 279 GLY ARG PHE LEU LYS PHE ASP ILE GLU ILE GLY ARG GLY SEQRES 3 B 279 SER PHE LYS THR VAL TYR LYS GLY LEU ASP THR GLU THR SEQRES 4 B 279 THR VAL GLU VAL ALA TRP CYS GLU LEU GLN ASP ARG LYS SEQRES 5 B 279 LEU THR LYS SER GLU ARG GLN ARG PHE LYS GLU GLU ALA SEQRES 6 B 279 GLU MET LEU LYS GLY LEU GLN HIS PRO ASN ILE VAL ARG SEQRES 7 B 279 PHE TYR ASP SER TRP GLU SER THR VAL LYS GLY LYS LYS SEQRES 8 B 279 CYS ILE VAL LEU VAL THR GLU LEU MET THR SER GLY THR SEQRES 9 B 279 LEU LYS THR TYR LEU LYS ARG PHE LYS VAL MET LYS ILE SEQRES 10 B 279 LYS VAL LEU ARG SER TRP CYS ARG GLN ILE LEU LYS GLY SEQRES 11 B 279 LEU GLN PHE LEU HIS THR ARG THR PRO PRO ILE ILE HIS SEQRES 12 B 279 ARG ASP LEU LYS CYS ASP ASN ILE PHE ILE THR GLY PRO SEQRES 13 B 279 THR GLY SER VAL LYS ILE GLY ASP LEU GLY LEU ALA THR SEQRES 14 B 279 LEU LYS ARG ALA ASP PHE ALA LYS SER VAL ILE GLY THR SEQRES 15 B 279 PRO GLU PHE MET ALA PRO GLU MET TYR ALA ALA ALA TYR SEQRES 16 B 279 ASP GLU SER VAL ASP VAL TYR ALA PHE GLY MET CYS MET SEQRES 17 B 279 LEU GLU MET ALA THR SER GLU TYR PRO TYR SER GLU CYS SEQRES 18 B 279 GLN ASN ALA ALA GLN ILE TYR ARG ARG VAL THR SER GLY SEQRES 19 B 279 VAL LYS PRO ALA SER PHE ASP LYS VAL ALA ILE PRO GLU SEQRES 20 B 279 VAL LYS GLU ILE ILE GLU GLY CYS ILE ARG GLN ASN LYS SEQRES 21 B 279 ASP GLU ARG TYR SER ILE LYS ASP LEU LEU ASN HIS ALA SEQRES 22 B 279 PHE PHE GLN GLU GLU THR HET 7AV A 501 33 HET ANP A 502 31 HET MN A 503 1 HET CA A 504 1 HET 7AV B 501 33 HET ANP B 502 31 HET MN B 503 1 HETNAM 7AV {2-[(4-CHLOROPHENYL)METHOXY]PHENYL}{5-[2-(METHYLAMINO)- HETNAM 2 7AV 1,3-THIAZOL-4-YL]-2,3-DIHYDRO-1H-INDOL-1-YL}METHANONE HETNAM ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER HETNAM MN MANGANESE (II) ION HETNAM CA CALCIUM ION FORMUL 3 7AV 2(C26 H22 CL N3 O2 S) FORMUL 4 ANP 2(C10 H17 N6 O12 P3) FORMUL 5 MN 2(MN 2+) FORMUL 6 CA CA 2+ FORMUL 10 HOH *90(H2 O) HELIX 1 AA1 THR A 258 LYS A 273 1 16 HELIX 2 AA2 THR A 308 LYS A 314 1 7 HELIX 3 AA3 LYS A 320 THR A 340 1 21 HELIX 4 AA4 ALA A 391 ALA A 396 1 6 HELIX 5 AA5 GLU A 401 SER A 418 1 18 HELIX 6 AA6 ASN A 427 SER A 437 1 11 HELIX 7 AA7 PRO A 441 VAL A 447 5 7 HELIX 8 AA8 ILE A 449 ILE A 460 1 12 HELIX 9 AA9 ASN A 463 ARG A 467 5 5 HELIX 10 AB1 SER A 469 ASN A 475 1 7 HELIX 11 AB2 HIS A 476 GLU A 481 1 6 HELIX 12 AB3 THR B 258 LYS B 273 1 16 HELIX 13 AB4 THR B 308 LYS B 314 1 7 HELIX 14 AB5 LYS B 320 THR B 340 1 21 HELIX 15 AB6 LYS B 351 ASP B 353 5 3 HELIX 16 AB7 ALA B 391 ALA B 397 1 7 HELIX 17 AB8 GLU B 401 SER B 418 1 18 HELIX 18 AB9 ASN B 427 SER B 437 1 11 HELIX 19 AC1 PRO B 441 VAL B 447 5 7 HELIX 20 AC2 ILE B 449 ILE B 460 1 12 HELIX 21 AC3 ASN B 463 ARG B 467 5 5 HELIX 22 AC4 SER B 469 ASN B 475 1 7 SHEET 1 AA1 6 GLY A 213 MET A 214 0 SHEET 2 AA1 6 PHE A 220 ARG A 229 -1 O LYS A 222 N GLY A 213 SHEET 3 AA1 6 LYS A 233 ASP A 240 -1 O VAL A 235 N ILE A 227 SHEET 4 AA1 6 VAL A 245 LEU A 252 -1 O TRP A 249 N TYR A 236 SHEET 5 AA1 6 ILE A 297 GLU A 302 -1 O LEU A 299 N CYS A 250 SHEET 6 AA1 6 PHE A 283 GLU A 288 -1 N TYR A 284 O VAL A 300 SHEET 1 AA2 2 ILE A 345 ILE A 346 0 SHEET 2 AA2 2 THR A 373 LEU A 374 -1 O THR A 373 N ILE A 346 SHEET 1 AA3 2 ILE A 355 THR A 358 0 SHEET 2 AA3 2 SER A 363 ILE A 366 -1 O LYS A 365 N PHE A 356 SHEET 1 AA4 6 GLY B 213 MET B 214 0 SHEET 2 AA4 6 PHE B 220 ARG B 229 -1 O LYS B 222 N GLY B 213 SHEET 3 AA4 6 LYS B 233 ASP B 240 -1 O VAL B 235 N GLY B 228 SHEET 4 AA4 6 GLU B 246 LEU B 252 -1 O TRP B 249 N TYR B 236 SHEET 5 AA4 6 LYS B 295 GLU B 302 -1 O ILE B 297 N LEU B 252 SHEET 6 AA4 6 PHE B 283 THR B 290 -1 N SER B 289 O CYS B 296 SHEET 1 AA5 2 ILE B 345 ILE B 346 0 SHEET 2 AA5 2 THR B 373 LEU B 374 -1 O THR B 373 N ILE B 346 SHEET 1 AA6 2 ILE B 355 ILE B 357 0 SHEET 2 AA6 2 VAL B 364 ILE B 366 -1 O LYS B 365 N PHE B 356 LINK OD1 ASN A 354 MN MN A 503 1555 1555 2.50 LINK OD2 ASP A 368 MN MN A 503 1555 1555 2.46 LINK O SER A 423 CA CA A 504 1555 1555 2.76 LINK O CYS A 425 CA CA A 504 1555 1555 2.84 LINK O1A ANP A 502 MN MN A 503 1555 1555 2.21 LINK CA CA A 504 O HOH A 637 1555 1555 2.85 LINK CA CA A 504 O HOH B 638 1555 2656 2.63 LINK OD1 ASN B 354 MN MN B 503 1555 1555 2.32 LINK OD2 ASP B 368 MN MN B 503 1555 1555 2.26 LINK O2A ANP B 502 MN MN B 503 1555 1555 2.72 LINK MN MN B 503 O HOH B 646 1555 1555 2.61 CISPEP 1 THR A 342 PRO A 343 0 -4.27 CISPEP 2 THR B 342 PRO B 343 0 -4.57 SITE 1 AC1 12 LEU A 252 ARG A 255 PHE A 265 GLU A 268 SITE 2 AC1 12 LEU A 272 VAL A 281 PHE A 283 LEU A 299 SITE 3 AC1 12 ASP A 368 LEU A 369 GLY A 370 ALA A 372 SITE 1 AC2 11 GLY A 228 GLY A 230 SER A 231 LYS A 233 SITE 2 AC2 11 ALA A 248 THR A 301 GLU A 302 MET A 304 SITE 3 AC2 11 LYS A 351 MN A 503 HOH A 601 SITE 1 AC3 3 ASN A 354 ASP A 368 ANP A 502 SITE 1 AC4 4 SER A 423 CYS A 425 HOH A 637 HOH B 638 SITE 1 AC5 11 PHE B 265 GLU B 268 LEU B 272 VAL B 281 SITE 2 AC5 11 PHE B 283 LEU B 299 ILE B 345 ASP B 368 SITE 3 AC5 11 LEU B 369 GLY B 370 ALA B 372 SITE 1 AC6 13 GLY B 228 ARG B 229 GLY B 230 SER B 231 SITE 2 AC6 13 LYS B 233 THR B 301 GLU B 302 LEU B 303 SITE 3 AC6 13 MET B 304 LYS B 351 ASP B 368 MN B 503 SITE 4 AC6 13 HOH B 602 SITE 1 AC7 5 ASN B 354 ASP B 368 ANP B 502 HOH B 625 SITE 2 AC7 5 HOH B 646 CRYST1 83.065 104.482 69.604 90.00 116.50 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012039 0.000000 0.006003 0.00000 SCALE2 0.000000 0.009571 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016054 0.00000